Sex-Based Differences in HIV Type 1 Pathogenesis
Open accessThe DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
Human immunodeficiency virus (HIV) remains a global infectious diseases threat that disproportionally affects women. Beyond social and political factors, biological and genetic differences have been identified that lead to differential disease courses and outcomes in men and women. Following HIV type 1 (HIV-1) seroconversion, women have up to 40% lower HIV loads and higher CD4(+) T-cell counts than men. However, at the same level of viremia, progression to AIDS is faster in women. After adjustment for viral load, HIV-positive women also display increased levels of generalized immune activation and experience the consequences of elevated inflammatory activity more frequently than men. Part of these observations are linked to sex-based differences in innate immunity, in which the differential ability of plasmacytoid dendritic cells to produce interferon α following stimulation of Toll-like receptor 7 and upregulation of interferon-stimulated genes play a central role. Here, we review the current knowledge and remaining gaps therein regarding sex-based differences in HIV-1 pathogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8
Heil, F., Hemmi, H., Hochrein, H., Ampenberger, F., Kirschning, C., Akira, S., Lipford, G., Wagner, H., & Bauer, S. (2004) · Science · doi:10.1126/science.1093620 · Cited by 3,947
Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
Rerks-Ngarm, S., Pitisuttithum, P., Nitayaphan, S., Kaewkungwal, J., Chiu, J., Paris, R., Premsri, N., Namwat, C., de Souza, M., Adams, E., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0908492 · Cited by 3,034 · cited 1×
“While only the RV144 trial showedmarginal overall vaccine efficacy [48], it has been illustrated in other vaccine models that failure to perform analysis with stratification by sex”
BackgroundTriant, V. A., Lee, H., Hadigan, C., & Grinspoon, S. K. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2190 · Cited by 1,613
The X-files in immunity: sex-based differences predispose immune responses
Fish, E. N. (2008) · Nature Reviews Immunology · doi:10.1038/nri2394 · Cited by 1,162 · cited 1×
“FOXP3, and CD40L, regulate immune function and might play an important role in modulating sex-based differences in immune-related diseases [35].”
BackgroundGlycoprotein-D–Adjuvant Vaccine to Prevent Genital Herpes
Stanberry, L. R., Spruance, S. L., Cunningham, A. L., Bernstein, D. I., Mindel, A., Sacks, S., Tyring, S., Aoki, F. Y., Slaoui, M., Denis, M., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011915 · Cited by 794
Persistent LCMV infection is controlled by blockade of type I interferon signaling
Teijaro, J. R., Ng, C., Lee, A. M., Sullivan, B. M., Sheehan, K. C. F., Welch, M., Schreiber, R. D., Carlos de la Torre, J., & Oldstone, M. B. A. (2013) · Science · doi:10.1126/science.1235214 · Cited by 755 · cited 1×
“quences for disease outcome, reflecting the important antiviral activity of IFN-α and IFN-α–induced genes during acute infection [29, 30].”
BackgroundBlockade of chronic type I interferon signaling to control persistent LCMV infection
Wilson, E. B., Yamada, D. H., Elsaesser, H., Herskovitz, J., Deng, J., Cheng, G., Aronow, B. J., Karp, C. L., & Brooks, D. G. (2013) · Science · doi:10.1126/science.1235208 · Cited by 709 · cited 1×
“quences for disease outcome, reflecting the important antiviral activity of IFN-α and IFN-α–induced genes during acute infection [29, 30].”
BackgroundBeignon, A.-S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26032 · Cited by 673 · cited 10×
“This has been specifically illustrated in the context of autoimmunity, such as systemic lupus erythematosus, an autoimmune disease with a female to male predominance of 7:1 and for which it was recently reported that the TLR7 and IFN-α pathways play a critical role [27].”
BackgroundInfluentialSex differences in the Toll-like receptor–mediated response of plasmacytoid dendritic cells to HIV-1
Meier, A., Chang, J. J., Chan, E. S., Pollard, R. B., Sidhu, H. K., Kulkarni, S., Wen, T. F., Lindsay, R. J., Orellana, L., Mildvan, D., et al. (2009) · Nature Medicine · doi:10.1038/nm.2004 · Cited by 594 · cited 1×
“the ability of pDCs to produce IFN-α [24].”
BackgroundSelf-citationTLR7 Ligands Induce Higher IFN-α Production in Females
Berghöfer, B., Frommer, T., Haley, G., Fink, L., Bein, G., & Hackstein, H. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.4.2088 · Cited by 480
Progesterone implants enhance SIV vaginal transmission and early virus load
Marx, P. A., Spira, A. I., Gettie, A., Dailey, P. J., Veazey, R. S., Lackner, A. A., Mahoney, C. J., Miller, C. J., Claypool, L. E., Ho, D. D., et al. (1996) · Nature Medicine · doi:10.1038/nm1096-1084 · Cited by 465 · cited 3×
“(DMPA) [12], the systemic administration of estrogens protected female rhesus macaques against intravaginal challenge with highly pathogenic SIV [13].”
BackgroundArruvito, L., Sanz, M., Banham, A. H., & Fainboim, L. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.4.2572 · Cited by 443
Sex differences in HIV-1 viral load and progression to AIDS
Farzadegan, H., Hoover, D. R., Astemborski, J., Lyles, C. M., Margolick, J. B., Markham, R. B., Quinn, T. C., & Vlahov, D. (1998) · The Lancet · doi:10.1016/s0140-6736(98)02372-1 · Cited by 416
Initial Plasma HIV-1 RNA Levels and Progression to AIDS in Women and Men
Sterling, T. R., Vlahov, D., Astemborski, J., Hoover, D. R., Margolick, J. B., & Quinn, T. C. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103083441003 · Cited by 357
Seillet, C., Laffont, S., Trémollières, F., Rouquié, N., Ribot, C., Arnal, J.-F., Douin-Echinard, V., Gourdy, P., & Guéry, J.-C. (2012) · Blood · doi:10.1182/blood-2011-08-371831 · Cited by 332
Lang, S., Mary-Krause, M., Cotte, L., Gilquin, J., Partisani, M., Simon, A., Boccara, F., Bingham, A., & Costagliola, D. (2010) · AIDS · doi:10.1097/qad.0b013e328339192f · Cited by 299
Klein, S. L. (2012) · BioEssays · doi:10.1002/bies.201200099 · Cited by 284 · cited 1×
“in the literature for a variety of pathogens [1].”
BackgroundMugo, N. R., Heffron, R., Donnell, D., Wald, A., Were, E. O., Rees, H., Celum, C., Kiarie, J. N., Cohen, C. R., Kayintekore, K., et al. (2011) · AIDS · doi:10.1097/qad.0b013e32834a9338 · Cited by 256 · cited 1×
“from females to males [14], but recent data from populationbased studies did not find these associations and in fact suggested a possibly decreased risk of HIV-1 acquisition during pregnancy”
ResultGuiducci, C., Tripodo, C., Gong, M., Sangaletti, S., Colombo, M. P., Coffman, R. L., & Barrat, F. J. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20101048 · Cited by 214 · cited 1×
“mune disease with a female to male predominance of 7:1 and for which it was recently reported that the TLR7 and IFN-α pathways play a critical role [27].”
BackgroundNoncalcified Coronary Atherosclerotic Plaque and Immune Activation in HIV-Infected Women
Fitch, K. V., Srinivasa, S., Abbara, S., Burdo, T. H., Williams, K. C., Eneh, P., Lo, J., & Grinspoon, S. K. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit508 · Cited by 206 · cited 2×
“revealed a 2-way interaction between age and sex, demonstrating that sCD163 increased more with age among women than among men [33].”
BackgroundSex, Race, and Geographic Region Influence Clinical Outcomes Following Primary HIV-1 Infection
Meditz, A. L., MaWhinney, S., Allshouse, A., Feser, W., Markowitz, M., Little, S., Hecht, R., Daar, E. S., Collier, A. C., Margolick, J., et al. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiq085 · Cited by 180 · cited 2×
“symptoms during primary infection, which may delay diagnosis in this population [7].”
BackgroundSelf-citationSex Differences in Longitudinal Human Immunodeficiency Virus Type 1 RNA Levels among Seroconverters
Sterling, T. R., Lyles, C. M., Vlahov, D., Astemborski, J., Margolick, J. B., & Quinn, T. C. (1999) · The Journal of Infectious Diseases · doi:10.1086/314967 · Cited by 180
Schulze zur Wiesch, J., Thomssen, A., Hartjen, P., Tóth, I., Lehmann, C., Meyer-Olson, D., Colberg, K., Frerk, S., Babikir, D., Schmiedel, S., et al. (2011) · Journal of Virology · doi:10.1128/jvi.01758-10 · Cited by 173
Sodora, D. L., Gettie, A., Miller, C. J., & Marx, P. A. (1998) · AIDS Research and Human Retroviruses · doi:10.1177/088922299801401s23 · Cited by 158 · cited 1×
“with the follicular phase (when the estrogen level is high), of their reproductive cycle [11] and had enhanced SIV acquisition following administration of depot-medroxyprogesterone acetate”
BackgroundMoore, A. L., Kirk, O., Johnson, A. M., Katlama, C., Blaxhult, A., Dietrich, M., Colebunders, R., Chiesi, A., Lungren, J. D., & Phillips, A. N. (2003) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200304010-00017 · Cited by 148 · cited 1×
“with equal access to care and correct administration of and compliance with ART, there is no significant sex-based difference in treatment response [50].”
BackgroundMartin, G. E., Gouillou, M., Hearps, A. C., Angelovich, T. A., Cheng, A. C., Lynch, F., Cheng, W., Paukovics, G., Palmer, C. S., Novak, R. M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055279 · Cited by 131 · cited 1×
“contribute to the elevated risk of inflammation-related diseases in HIV-1–positive women [34].”
BackgroundPolis, C. B., & Curtis, K. M. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70155-5 · Cited by 130 · cited 2×
“analysis concluded that all reviewed trials studying norethisterone enanthate and most of the studies on oral contraceptives did not demonstrate an increased acquisition risk [16].”
BackgroundResultDo gender differences in CD4 cell counts matter?
Prins, M., Robertson, R., Brettle, R. P., Hernández‐Aguado, I., Broers, B., Boufassa, F., Goldberg, D. J., Zangerle, R., Coutinho, R. A., & van den Hoek, A. (1999) · AIDS · doi:10.1097/00002030-199912030-00007 · Cited by 128
Topical estrogen protects against SIV vaginal transmission without evidence of systemic effect
Smith, S. M., Mefford, M., Sodora, D. L., Klase, Z. A., Singh, M., Alexander, N. J., Hess, D. L., & Marx, P. A. (2004) · AIDS · doi:10.1097/01.aids.0000131393.76221.cc · Cited by 121 · cited 3×
“(DMPA) [12], the systemic administration of estrogens protected female rhesus macaques against intravaginal challenge with highly pathogenic SIV [13].”
BackgroundChang, J. J., Woods, M., Lindsay, R. J., Doyle, E., Griesbeck, M., Chan, E. S., Robbins, G. K., Bosch, R. J., & Altfeld, M. A. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit262 · Cited by 120 · cited 1×
“of 98 genes involved in the TLR and type I IFN signaling pathways on populations of flow-sorted T cells and DCs derived from men and women with untreated chronic HIV-1 infection [26].”
BackgroundSelf-citationSex differences in adverse reactions to antiretroviral drugs.
Ofotokun, I., & Pomeroy, C. (2003) · PubMed · Cited by 116
Afshan, G., Afzal, N., & Qureshi, S. (2012) · PubMed · Cited by 111
Tran, T.-A., de Herve, M.-G. D. G., Hendel, H., Dembelé, B., le Névot, E., Abbed, K., Pallier, C., Goujard, C., Gasnault, J., Delfraissy, J., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003305 · Cited by 107 · cited 1×
“may contribute to the promotion of Tregs as part of the HIV-1 latent reservoir [40].”
BackgroundCurrier, J. S., Spino, C., Grimes, J. M., Wofsy, C. B., Katzenstein, D. A., Hughes, M. D., Hammer, S. M., & Cotton, D. J. (2000) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00042560-200008010-00003 · Cited by 99 · cited 1×
“which led to increased rates of treatment nonadherence among women [52].”
BackgroundDevelopment of prophylactic vaccines against HIV-1
Schiffner, T., Sattentau, Q. J., & Dorrell, L. (2013) · Retrovirology · doi:10.1186/1742-4690-10-72 · Cited by 84 · cited 1×
“cine trials [47], study populations in 3 were exclusively or >94% male.”
BackgroundAngin, M., Kwon, D. S., Streeck, H., Wen, F., King, M., Rezai, A., Law, K., Hongo, T. C., Pyo, A., Trocha, A. K., et al. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis236 · Cited by 69
Self-citationOdorizzi, P. M., & Wherry, E. J. (2013) · Science · doi:10.1126/science.1237568 · Cited by 68
Touloumi, G., Pantazis, N., Babiker, A. G., Walker, A. S., Κατσαρού, Ό., Karafoulidou, A., Hatzakis, A. E., & Porter, K. (2004) · AIDS · doi:10.1097/01.aids.0000131395.14339.f5 · Cited by 66
Gender difference in CD4+ cell counts persist after HIV-1 infection. SEROCO Study Group.
Mc, D., Jadand, C., Vincenzi, D., Deveau, C., Persoz, A., Sobel, A. T., Kazatchkine, M. D., Jb, B., & Meyer, L. (1997) · PubMed · Cited by 66
CCR5 Expression Is Elevated on Endocervical CD4+ T Cells in Healthy Postmenopausal Women
Meditz, A. L., Moreau, K. L., MaWhinney, S., Gozansky, W. S., Melander, K., Kohrt, W. M., Wierman, M. E., & Connick, E. (2011) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31823fd215 · Cited by 61 · cited 1×
“Meditz et al recently described increased levels of CCR5 expression on endocervical CD4 T cells in postmenopausal women, which may increase the risk for HIV-1 acquisition in older women [20].”
BackgroundHolmes, D., Knudsen, G. T., Mackey-Cushman, S., & Su, L. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702051200 · Cited by 52
X Chromosomal Variation Is Associated with Slow Progression to AIDS in HIV-1-Infected Women
Siddiqui, R. A., Sauermann, U., Altmüller, J., Fritzer, E., Nothnagel, M., Dalibor, N., Fellay, J., Kaup, F., Stahl‐Hennig, C., Nürnberg, P., et al. (2009) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2009.07.013 · Cited by 51 · cited 2×
“AIDS-related disease in rhesus macaques [36].”
BackgroundCho, J., Kim, L., Li, Z., Rose, N. R., Talor, M. V., & Njoku, D. B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061186 · Cited by 47 · cited 1×
“responsible for the sex bias in immune-mediated drug-induced liver injury [38].”
BackgroundRichardson, K. M., & Weinberg, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028172 · Cited by 34 · cited 2×
“tion of fetal rejection andmay in part explain the increased risk of abortion in HIV-1–infected women [42].”
BackgroundSmith, K. Y., Tierney, C., Mollan, K. R., Venuto, C. S., Budhathoki, C., Ma, Q., Morse, G. D., Sax, P., Katzenstein, D. A., Godfrey, C., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit747 · Cited by 33 · cited 1×
“Self-reported adherence did not differ significantly by sex, but interestingly, females had slower ATV clearance and higher predose levels of ATV, compared with men [54].”
ResultCu‐Uvin, S., Wright, D. J., Anderson, D. J., Kovács, A., Watts, D. H., Cohn, J. A., LANDAY, A. L., & Reichelderfer, P. S. (2000) · Journal of Women s Health & Gender-Based Medicine · doi:10.1089/152460900750020883 · Cited by 29
Thymic function in HIV-infection.
Kolte, L. (2013) · PubMed · Cited by 28
Cited by
How sex and age affect immune responses, susceptibility to infections, and response to vaccination
Giefing‐Kröll, C., Berger, P., Lepperdinger, G., & Grubeck‐Loebenstein, B. (2015) · Aging Cell · doi:10.1111/acel.12326 · Cited by 761
Sex differences in vaccine-induced humoral immunity
Fischinger, S., Boudreau, C. M., Butler, A. L., Streeck, H., & Alter, G. (2019) · Seminars in Immunopathology · doi:10.1007/s00281-018-0726-5 · Cited by 410
Mechanisms of long COVID and the path toward therapeutics
Peluso, M. J., & Deeks, S. G. (2024) · Cell · doi:10.1016/j.cell.2024.07.054 · Cited by 341
Sex and gender affect immune aging
Calabrò, A., Accardi, G., Aiello, A., Caruso, C., & Candore, G. (2023) · Frontiers in Aging · doi:10.3389/fragi.2023.1272118 · Cited by 71
The potency of mesenchymal stem/stromal cells: does donor sex matter?
Maged, G., Abdelsamed, M. A., Wang, H., & Lotfy, A. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-03722-3 · Cited by 42
“HIV infection also showed genetic disparities between males and females, and unequally affects women more than men [62, 63].”
Background
Metadata
- Authors
- Addo, M. M., & Altfeld, M.
- Venue
- Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-06-25
- Volume
- 209
- Issue
- suppl 3
- Pages
- S86-S92
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2061480204
- Cited by
- 162
- References
- 47
- FWCI
- 5.53
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.